Skip to main content

Global prevalence of diabetes continues to rise

To mark World Diabetes Day, the International Diabetes Federation (IDF) published new estimates on the global prevalence of diabetes, indicating that 1 in 11 adults are currently living with diabetes, 10 million more than in 2015.The new estimate is included in the eighth edition of the IDF Diabetes Atlas, other data included: diabetes prevalence is set to rise to almost 700 million by 2045; one in two adults with diabetes remain undiagnosed; and 12 percent of global health expenditure is spent on diabetes. For more information click here.

NICE guideline publication - Type 2 diabetes: prevention in people at high risk

This guideline covers how to identify adults at high risk of type 2 diabetes. It aims to remind practitioners that age is no barrier to being at high risk of, or developing, the condition. It also aims to help them provide those at high risk with an effective and appropriate intensive lifestyle-change programme to prevent or delay the onset of type 2 diabetes. For more information click HERE.

John Wales - Founding member of ABCD

I am extremely saddened to advise you of the unexpected death of our Founding Chairman, Dr John Wales who passed away suddenly, in his sleep, whilst on holiday in Finland.  John’s funeral took place in Acaster, Selby, North Yorkshire on Friday 1/9/2017 with a private family burial. Professor Ken Shaw and Dr Chris Walton were able to attend and represent ABCD at the following memorial service. I have sent a personal message to Barbara, John’s wife and will write to her on behalf of ABCD.

NHS Business Services Authority has approved the listing of the FreeStyle Libre® flash glucose monitoring system in the Drug Tariff

September 13, 2017 — The NHS Business Services Authority has approved the listing of the FreeStyle Libre® flash glucose monitoring system in the Drug Tariff (under section 9A: Detection Sensor, interstitial fluid for glucose).   This means, subject to local health economy approval, it will be available for reimbursement via the NHS across England and Wales, NHS Scotland and Health and Social Care in Northern Ireland from 1st November 2017.